BAMCO Inc
TEVA icon

BAMCO Inc’s Teva Pharmaceuticals TEVA Stock Holding History

BAMCO Inc’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$4.71M Buy
138,987
+8,987
+7% +$299K 0.01% 261
2026
Q1 		$3.92M Buy
130,000
+10,000
+8% +$322K 0.01% 254
2025
Q4 		$3.75M Buy
120,000
+10,000
+9% +$246K 0.01% 266
2025
Q3 		$2.22M Buy
110,000
+10,000
+10% +$176K 0.01% 276
2025
Q2 		$1.68M Buy
+100,000
New +$1.61M ﹤0.01% 278

Other funds holding TEVA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
HIIFS
Harel Insurance Investments & Financial Services Ramat Gan, Israel $20.6B AUM 59.59% 1-Year Est. Return
PF
Phoenix Financial Givatayim, Israel $14.6B AUM 57.48% 1-Year Est. Return
WCM Investment Management
WCM Investment Management Laguna Beach, California $55.2B AUM 57.07% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $22.3B AUM 79.91% 1-Year Est. Return
MMH
Menora Mivtachim Holdings Ramat Gan, Israel $25.6B AUM 50.04% 1-Year Est. Return
MIFH
Migdal Insurance & Financial Holdings Petach Tikva, Israel $15.6B AUM 71.29% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
LIM
Lingotto Investment Management London, United Kingdom $4.67B AUM 70.24% 1-Year Est. Return

BAMCO Inc's TEVA Position: Q2 2026 in Review

BAMCO Inc increased its Teva Pharmaceuticals (TEVA) stake by 6.9% in Q2 2026, buying an estimated $299K and bringing the position to 138,987 shares worth $4.71M. The position accounts for 0.01% of the portfolio, ranked #261.

BAMCO Inc first reported a position in TEVA in Q2 2025 and has held it in 5 quarters since. 672 funds tracked by Wall St. Rank hold TEVA as of Q2 2026.

  • BAMCO Inc held 138,987 shares of Teva Pharmaceuticals worth $4.71M as of Q2 2026.
  • BAMCO Inc bought 8,987 Teva Pharmaceuticals shares in Q2 2026, an estimated $299K.
  • Teva Pharmaceuticals made up 0.01% of BAMCO Inc's portfolio in Q2 2026, its #261 holding.
  • BAMCO Inc first reported a position in Teva Pharmaceuticals in Q2 2025 and has held it in 5 quarters since.
  • 672 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q2 2026.

Based on BAMCO Inc's 13F filing for Q2 2026, filed 14 Aug 2026.